Egalet (STU:EGP) Construction In Progress: €0.00 Mil (As of Mar. 2020)


What is Egalet Construction In Progress?

Egalet STU:EGP Construction In Progress is €0.00 Mil as of Mar. 2020. The stock has 2 warning signs investors should review.

Egalet's annual construction in progress declined from Dec. 2017 (€0.20 Mil) to Dec. 2018 (€0.00 Mil) but then stayed the same from Dec. 2018 (€0.00 Mil) to Dec. 2019 (€0.00 Mil).

Egalet Construction In Progress Historical Data

* Premium members only.

The historical data trend for Egalet's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egalet Construction In Progress Chart

Egalet Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 3.29 0.00 0.20 0.00 0.00

Egalet Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Egalet Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €0.00 Mil mean?
Egalet (STU:EGP) has a Construction In Progress of €0.00 Mil as of Mar. 2020. Construction in Progress records the amount of construction work that is not complete. View historical data on Egalet and its competitors.
Is Egalet's Construction In Progress too high?
Egalet's current Construction In Progress is €0.00 Mil.
How does Egalet's Construction In Progress compare to CPHI and TLGT?
Egalet's Construction In Progress of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Egalet and its competitors. Egalet's current Construction In Progress is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egalet stock overvalued right now?
Egalet (STU:EGP) has a current Construction In Progress of €0.00 Mil. The current Construction In Progress is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Egalet (STU:EGP), the current Construction In Progress is €0.00 Mil as of Mar. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Egalet Business Description

Address 600 Lee Road, Suite 100, Wayne, PA, USA, 19087
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.